Latest stories on IMVT
H.C. Wainwright Raises Price Target on Immunovant (IMVT) Following Positive Rheumatoid Arthritis Trial Data
Yahoo Top61 · neutralanalyst
Truist Lifts PT on Immunovant, Inc. (IMVT) But Maintains a Hold Rating
Yahoo Top58 · neutralanalyst
Immunovant: Upgraded To 'Buy' Because Of IMVT-1402's Broad Potential
Seeking Alpha61 · neutralanalyst
Immunovant (IMVT) Hits 5-Year High on Stellar Arthritis Treatment Trial
Yahoo Top86 · bullishproduct/pr
Can a New Arthritis Drug Make Immunovant the Next Biotech Star?
Barron's67 · bullishproduct/pr
Can a New Arthritis Drug Make Immunovant the Next Biotech Star?
Yahoo Top67 · bullishproduct/pr
This Is Why Immunovant Stock (IMVT) Is Up Today
TipRanks61 · neutralgeneral
IMVT-1402 Shows 72.7% Response Rate at Week 16 in Challenging RA Patients: Immunovant Preps for Key Data in 2026
MarketChameleon77 · bullishproduct/pr
Immunovant Stock Surges 22% on Trial Data. Earnings Are an Afterthought.
Barron's77 · bullishearnings
Immunovant Shares Rally on Positive Trial Results Despite Earnings Miss (IMVT)
Yahoo Top61 · neutralearnings
IMVT-1402 Achieves 72.7% Response Rate in Difficult-to-Treat RA as Immunovant Prioritizes Pipeline Progress
MarketChameleon67 · bullishproduct/pr
Immunovant Q4 2026 Earnings Preview
Seeking Alpha50 · neutralearnings